# FDA Inspection 1210103 - Lupin Limited - July 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/lupin-limited/17123b34-eaa9-495e-b832-4865ddc69e72
Source feed: FDA_Inspections

> FDA Inspection 1210103 for Lupin Limited on July 11, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210103
- Company Name: Lupin Limited
- Inspection Date: 2023-07-11
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1296412 - 2025-11-14](https://www.keypedia.com/records/fda_inspections/lupin-limited/ec5f628c-9c0b-4b82-8176-86f26fba2519)
- [FDA Inspection 1102191 - 2019-08-08](https://www.keypedia.com/records/fda_inspections/lupin-limited/93c81130-fa7b-49cc-9548-05a424e2bed3)
- [FDA Inspection 1056627 - 2018-05-11](https://www.keypedia.com/records/fda_inspections/lupin-limited/c7153f93-6eb0-4b83-8659-ca50878a5fc4)
- [FDA Inspection 921988 - 2015-03-27](https://www.keypedia.com/records/fda_inspections/lupin-limited/cd353183-e86c-4ce2-ad94-523ac3d7f75b)

Company: https://www.keypedia.com/companies/lupin-limited/50f7d9dc-5597-42d6-b580-2154a13534ae

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c